Back to search results
Completed

Migraine

A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine

CGAW | {{ defaultRegistry.registryAnchorText }} NCT03559257 {{ currentLocaleObject.registryAnchorText }}

Study Purpose

The purpose of this study is to assess the safety and efficacy of galcanezumab in people with treatment-resistant episodic or chronic migraine.

Completed Study

The results of this study are not yet available.

Time Commitment

The study will last about 8 months and may include up to 9 visits.

Who Participated? Tool Tip Icon

Here you can find out a bit more about the requirements for volunteers who took part in this study

Gender

Male Female

Age

18 years
75 years

• Participants must have a diagnosis of migraine or chronic migraine • Participants must have a history of migraine headaches at least 1 year prior to screening, with onset prior to age 50 • Participants must have failed previous migraine preventive medications in the past 10 years due to inadequate efficacy or tolerability • Participants must not be currently enrolled in or have participated within the last 30 days or within 5 half-lives (whichever is longer) in a clinical trial involving an investigational product • Participants must not currently use or have prior exposure to galcanezumab or another CGRP antibody • Participants must not have a history of persistent daily headache, cluster headache or migraine subtypes including hemiplegic (sporadic or familial) migraine, ophthalmoplegic migraine, and migraine with brainstem aura (basilar-type migraine) • Participants must not be pregnant or nursing

Where This Study Took Place Tool Tip Icon

Where This Study Took Place Tool Tip Icon

Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Closest Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Other Location(s)
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.